PVG Asset Management’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$544K Hold
79,573
– – 0.37% 61
2026
Q2
$563K Sell
79,573
-190
-0.2% -$1.08K 0.33% 69
2026
Q1
$506K Buy
79,763
+28,131
+54% +$218K 0.3% 70
2025
Q4
$398K Sell
51,632
-81,272
-61% -$637K 0.85% 37
2025
Q3
$946K Sell
132,904
-16,860
-11% -$122K 3.48% 5
2025
Q2
$1.08M Sell
149,764
-24,615
-14% -$170K 3.66% 3
2025
Q1
$1.03M Buy
174,379
+6,274
+4% +$30.8K 4.48% 4
2024
Q4
$657K Buy
168,105
+560
+0.3% +$3.06K 3.11% 12
2024
Q3
$947K Buy
167,545
+9,005
+6% +$46.4K 3.8% 5
2024
Q2
$894K Buy
+158,540
New +$652K 3.54% 10

Other funds holding DERM

PVG Asset Management's DERM Position: Q3 2026 in Review

PVG Asset Management held its Journey Medical (DERM) position steady in Q3 2026 at 79,573 shares worth $544K. The position accounts for 0.37% of the portfolio, ranked #61.

PVG Asset Management first reported a position in DERM in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.08M in Q2 2025. 7 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • PVG Asset Management held 79,573 shares of Journey Medical worth $544K as of Q3 2026.
  • PVG Asset Management left its Journey Medical share count unchanged in Q3 2026.
  • Journey Medical made up 0.37% of PVG Asset Management's portfolio in Q3 2026, its #61 holding.
  • PVG Asset Management first reported a position in Journey Medical in Q2 2024 and has held it in 10 quarters since.
  • PVG Asset Management's Journey Medical position peaked at $1.08M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on PVG Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.